CA-NETAPP
NetApp® (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced the availability of NetApp Advance, a new portfolio of storage programs and guarantees to help customers cost-effectively future proof on-premises environments.
NetApp Advance evolves the storage lifecycle, allowing organizations the possibility to avoid complex, costly, and time-consuming refresh cycles by enabling ongoing, non-disruptive hardware upgrades – and ensures efficient, secure and sustainable storage with new guarantees offered to meet the needs of organizations today.
With simplified storage ownership and management, NetApp Advance can help to eliminate complex, time-consuming, and costly upgrade cycles while staying current with technology innovations. Organizations can choose on-premises or cloud storage options to future-proof environments to scale securely, seamlessly, and non-disruptively as they grow. Advance also brings sustainability and efficiency best practices and capabilities that continually improve energy efficiency and operational performance to reduce carbon footprint.
“NetApp Advance brings peace of mind to forward looking organizations in need of storage solutions that can adapt and scale as their business changes and grows,” said Sandeep Singh, Senior Vice President, Enterprise Storage at NetApp. “With NetApp Advance, we’re offering customers the confidence that their storage investment today will provide the flexibility to meet their hybrid cloud needs for the future.”
New benefits of NetApp Advance include:
- Reducing the cost, complexity, and disruption of tech refreshes by buying once and evolving continuously.
- Greatly reducing the risk previously associated with the journey to hybrid cloud with the flexibility to easily scale out to the cloud if or when business demands it.
Part of NetApp Advance, the new NetApp Storage Lifecycle Program offers:
- No additional cost non-disruptive upgrades to the latest storage controller technology every three, four, or five years
- Option to upgrade controllers at only incremental cost prior to three-year renewal.
- Optional capacity refresh allowing customers to replace lower capacity drives as part of a storage refresh, so customers never have to buy the same capacity twice and can achieve a more efficient & sustainable data center footprint.
- Remotely managed software updates including non-disruptive ONTAP software upgrades packed with new capabilities and enhancements.
- Premier-level support services, with Active IQ and Cloud Insights that enable full-stack visibility and AIOps to streamline observability of the infrastructure beyond the storage layer in a single interface to quickly pinpoint issues and simplify troubleshooting. While ONTAP Essentials provides detailed overviews of ONTAP inventories, workloads, and data protection.
Additionally, the NetApp Storage Lifecycle Program introduces the NetApp Cloud Advantage Program, which allows organizations to trade in controllers for full credit toward their choice of NetApp cloud solutions to enable easy scale out to the cloud in order to meet changing business demands – and two new guarantees to benefit organizations in need of agile and efficient storage consumption options and models.
NetApp’s 4:1 SAN Storage Efficiency Guarantee offers that if workload efficiency goals are not met, NetApp will rectify this at no cost to the customer. Available for all AFF all-flash systems.*
NetApp will also introduce a new Sustainability SLA for NetApp Keystone customers. Keystone comes standard with 99.999 percent data availability.* Now Keystone will provide a standard Watts/TB for each SLA-based performance level, with service credits available if those targets are not met. This new SLA is planned for availability in the first calendar quarter of 2023 and specific terms and conditions will apply.
With NetApp BlueXP, customers will soon have access to a new, industry-first Sustainability Dashboard – available for preview in the first quarter of NetApp’s fiscal year 2024. This dashboard provides a holistic view of an organization’s IT environment with real data measuring power, energy and heat usage to deliver a sustainability scorecard. By offering actionable insights with AIOps to improve their overall score and reduce their storage carbon footprint, organizations can simply and easily monitor and achieve their IT sustainability goals.
“As a NetApp partner, EVT is helping our joint customers optimize their IT environment and accelerate their journey to the cloud,” said Scott Gelb, Solutions Architect at Enterprise Vision Technologies. “With NetApp’s announcement of NetApp Advance, we’re now perfectly positioned to help customers do just that by providing a flexible path to non-disruptive upgrades of their on-premises hardware systems, or to right-size their hybrid cloud environments as they scale out to any cloud with credits toward their choice of NetApp cloud solutions. By future-proofing their investment with Advance, we can limit risk and offer infrastructure agility as their business evolves.”
NetApp Advance is available today. Also announced today, the upcoming availability of NetApp AFF C-Series, a new family of capacity flash storage options that deliver lower cost all-flash storage, and NetApp AFF A150, a new entry-level storage system in the AFF A-Series family of all-flash systems.
*Terms and conditions will apply.
Additional Resources
- NetApp Advance
- Blog: Fresh NetApp Innovation to Revolutionize Your Data Center
- Blog: Future-Proof Your Storage Investments with NetApp Advance
- Blog: If You Can’t Measure Sustainability, You Can’t Manage It
- Press Release: NetApp Announces New Line of High-Capacity, Low-Cost Flash Storage for the Modern Data Center
About NetApp
NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services, and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005469/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
